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ABSTRACT 
Healthcare-Associated Infection and Exposure to Infected or Colonized  
Concurrent Roommates and Prior Bed Occupants 
Bevin Cohen 
This dissertation examines factors associated with healthcare-associated infections 
(HAIs) in four acute care hospitals located in New York City.  Specifically, this investigation 
focuses on the role that the physical environment plays with regard to patient-to-patient 
transmission.   
The initial analyses describe the scope of the problem by reporting the incidence of HAIs 
and antimicrobial resistance over a seven-year period in the study institutions.  In total, 19,052 
HAIs were identified among 761,426 discharges.  HAI rates fell over time within all hospitals 
and for all organisms and infection types included in the study, and the odds of acquiring an HAI 
decreased significantly over time for all organisms.  Resistance levels were stable for 
Enterococcus spp., Staphylococcus aureus, Acinetobacter baumannii, and Streptococcus 
pneumoniae.  Multidrug resistance increased for Pseudomonas aeruginosa and decreased for 
Klebsiella pneumoniae, though imipenem resistance among K. pneumoniae climbed sharply in 
2011.   
A systematic literature review is presented to summarize what is known and unknown 
about how patients’ exposure to infected or colonized concurrent roommates and prior bed 
occupants affects their risk of developing HAIs.  Eighteen articles meeting the inclusion criteria 
were identified.  More than half reported at least one statistically significant positive association 
between the infection/colonization status of a roommate or previous room occupant and the 
development of HAIs.  Only a single article identified a statistically significant negative 
association.  The remainder found no associations that reached statistical significance, though 
this may be due to the fact that they were insufficiently powered. 
The dissertation concludes with a matched case-control study designed to quantify the 
association between having a prior bed occupant or roommate with a positive blood, respiratory, 
urine, or wound culture and subsequent infection with the same organism.  In a multivariable 
analysis controlling for patient characteristics and mutually controlling for each exposure, the 
odds of being exposed to a prior bed occupant with the same organism were 5.83 (95% 
Confidence Interval [3.62, 9.39]) times greater for cases versus controls and the odds of being 
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Healthcare-associated infections (HAIs) are endemic in healthcare institutions throughout 
the world and are considered to be one of the greatest safety threats to hospitalized patients.1-3 
Since the 1970s, focus on the development, implementation, and evaluation of hospital infection 
prevention and control programs has grown substantially.4-5 Yet, HAIs remain a major issue, 
both in hospitals and long-term and sub-acute care settings.6-8 The most recent estimates for 
acute care hospitals in the United States (US) indicate that approximately four percent of patients 
contract at least one HAI during their stay; this amounts to more than 700,000 infections each 
year.9  Nearly six percent of patients who develop HAIs die as a direct or indirect result of their 
infections, making HAIs one of the top 10 causes of death in US hospitals.10,11 Patients who 
survive HAIs endure longer recovery periods, increased exposure to surgical and other 
therapeutic interventions, prolonged courses of antibiotics and other medications, and loss of life 
quality and productivity.12  
Beyond the morbidity and mortality suffered by individual patients with HAIs, infections 
in hospitals also have a broader impact on the healthcare system as a whole.  Patients, hospitals 
and insurers must bear the financial burden of HAIs, which includes all marginal costs associated 
with each additional day of hospitalization, costs of therapeutic interventions necessitated by the 
infection, and costs of preventing the spread of infection to other patients through the use of 
isolation rooms, personal protective equipment (PPE) such as gowns, gloves and masks, and 
additional laboratory testing.12-14 Current estimates suggest that the increased length of stay and 
total cost attributable to HAIs are five to ten days and $12,000-$21,000 per infection, though 
studies have reported a wide range of figures totaling as high as $260,000.11,15,16 There is a strong 
incentive to reduce the incidence of HAIs both from a patient welfare perspective and from an 




treating hospital-acquired complications that are thought to be preventable, including several 
types of infections.17,18  
Infection transmission dynamics in healthcare environments involve a complex network 
of factors.  The potential for pathogenic organisms to be transferred from patient to patient is 
dependent on the interplay between biological properties of infectious agents, behavioral 
practices of staff, underlying medical conditions of patients, organization of the built 
environment, and tools and protocols designed to interrupt transmission (Table 1.1).19  





 Efficiency of spread through various modes of transmission, e.g., 
direct and indirect contact, droplet, and airborne 
 Viability and survival time under a range of environmental conditions 
 Susceptibility to cleaning agents and methods of mechanical removal 
Behavioral practices 
of staff22-25 
 Adherence to hand hygiene and isolation protocols 





 Age and severity of illness 
 Immunosuppression and use of high-risk medications 
 Use of indwelling devices and invasive procedures 
Organization of the 
built environment27,28 
 Availability of isolation rooms 
 Placement of sinks, bathrooms, utility rooms, and trash and linen 
receptacles 
Tools and protocols 
designed to interrupt 
transmission29,30 
 Patient isolation protocols 
 Cleaning and sterilization procedures for patient rooms, shared 
equipment, public spaces, and staff areas, e.g., computer terminals 
and nurses stations 
 Care bundles designed to prevent infections in patients undergoing 
high-risk procedures or device use 
 
Although little is known about the relative importance of the physical environment with 
regard to infection transmission, there is a growing consensus that environmental contamination 
does contribute to the spread of HAIs.28,31-39 There are several pathways through which 
susceptible patients could be exposed to pathogens in the environment.  One method of exposure 
is direct contact.  All patients have direct contact with objects in their immediate surroundings, 




Ambulatory patients can have direct contact with portable (e.g., chairs, tables, curtains) and fixed 
(e.g., walls, floors, bathrooms) surfaces within their assigned rooms and in common recreation or 
therapy areas.  Patients could also be exposed to pathogens in the environment through indirect 
contact with healthcare workers, supplies, or equipment serving as vectors.35 If pathogens 
become aerosolized or suspended as droplets, patients could be exposed through inhalation or 
contact with mucous membranes.39  
Just as patients can be exposed to environmental pathogens via several different 
pathways, the environment can likewise be contaminated in a multitude of ways.  All patients 
can contaminate their immediate bedside surroundings through direct contact.  Ambulatory 
patients may also contaminate other areas of their assigned rooms or shared spaces through direct 
contact.  Indirect contact mediated by healthcare workers could be another source of 
contamination in the environment, as hands, PPE, uniforms, supplies, and equipment are easily 
soiled during patient care.40 The impact of indirect contact may be especially great since 
healthcare workers move throughout a unit and, in some cases, throughout one or more hospitals, 
thereby providing opportunities for organisms to spread to a vast environmental network.41 The 
environment may also become contaminated in ways not mediated by healthcare worker 
interaction with patients.  Methicillin-resistant Staphylococcus aureus (MRSA) and Norwalk 
virus, for example, may become suspended in the air and land on surfaces.39,42 Spore-producing 
bacteria such as Clostridium difficile and desiccation-resistant bacteria such as MRSA can be 
spread via dust particles without the aid of contact with contaminated hands or equipment.39 
Cleaning supplies such as mops and buckets may also be a vehicle for spreading bacteria from 




Given the intricacy of elements that contribute to the spread of infectious organisms in 
healthcare settings, isolating the effects of any one source of exposure is challenging.  While 
previous authors have hypothesized that prior bed occupants and hospital roommates may be 
important sources of exposure to pathogenic organisms that cause HAIs, few have studied the 
risks associated with such exposures and none have done so in a comprehensive acute care 
hospital setting.43 The purpose of this dissertation was to conduct a thorough evaluation of the 
roles that prior bed occupants and hospital roommates play in the transmission of HAIs.  The 
results of three related studies are presented in the subsequent chapters.  To understand the 
magnitude of the problem posed by HAIs, Chapter Two provides a descriptive analysis of the 
incidence of HAIs and antimicrobial resistance in four acute care hospitals over a seven-year 
period.  Chapter Three summarizes and synthesizes the research published to date on the 
relationship between exposure to infected or colonized prior room occupants and roommates and 
subsequent colonization or infection with the same organism.  Chapter Four presents the results 
of a case-control study designed to quantify the association between the onset of HAIs and 
exposure to infected or colonized prior room occupants and hospital roommates for six 













Changes in the Incidence and Antimicrobial Susceptibility of Healthcare-Associated Infections 
























Although national efforts to curtail healthcare-associated infections (HAI) have 
proliferated, data detailing progress over time are limited.  This study aims to describe changes 
in incidence and antimicrobial susceptibility of HAI in four New York City hospitals within the 
same network over seven years.  Electronic data were collected retrospectively for all patient 
discharges between 2006 through 2012.  Previously validated computerized algorithms based on 
National Healthcare Safety Network criteria were used to detect bloodstream infections, 
pneumonia, surgical site infections, and urinary tract infections with six organisms commonly 
associated with HAI: Enterococcus spp., Staphylococcus aureus, Streptococcus pneumoniae, 
Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae.  Antimicrobial 
susceptibilities were obtained from electronic laboratory records.  Logistic regression was used 
to assess changes in odds of acquiring an HAI and odds of antimicrobial resistance over time, 
controlling for age, gender, severity of illness, previous hospitalizations, and admission source.  
In total, 19,052 HAI were identified among 761,426 discharges.  HAI rates fell over time for all 
organisms, all infection types, and within all hospitals, and the odds of acquiring an HAI 
decreased significantly over time for all organisms.  Resistance levels were stable for 
Enterococcus spp., S. aureus, A. baumannii, and S. pneumoniae.  Multidrug resistance increased 
for P. aeruginosa and decreased for K. pneumoniae, though imipenem resistance among K. 
pneumoniae climbed sharply in 2011.  This study suggests that HAI incidence rates are falling, 
possibly due to increased federal, state and local attention to healthcare quality and patient 
safety.  Though we found no substantial reductions in resistance, recent national attention 






Healthcare-associated infections (HAI) remain endemic in United States (US) healthcare 
facilities despite growing emphasis on infection prevention and control programs designed to 
curtail their spread.44  The latest national data released by the Centers for Disease Control and 
Prevention (CDC) National Healthcare Safety Network (NSHN) show notable decreases for 
some HAI including central line-associated bloodstream infections (BSI) and certain types of 
surgical site infections (SSI).8  However, national longitudinal data are available only for the 
selected types of HAI tracked by the NHSN, which are limited primarily to procedure- and 
device-associated infections.  The NHSN data also reveal substantial differences across regions 
and states, emphasizing the importance of monitoring trends at the local level.8 
Antimicrobial resistance among common healthcare pathogens is similarly persistent in 
hospitals, even with advances in stewardship efforts and transmission-based precautions for 
patients with drug-resistant organisms.45-47  Multidrug-resistant phenotypes are implicated in 
more than 20 percent of HAI nationally, though prevalence varies considerably by region and 
institution.48  The CDC’s most recent comprehensive report on antimicrobial susceptibilities 
shows only slight changes in resistance for most organisms over the past several years, but data 
are likewise limited to specific types of HAI and trends are evaluated for only a short time 
period.48   
In light of the need for longitudinal data at the local level, this study aims to describe 
changes in the epidemiology of HAI in four New York City hospitals over a seven-year period 
from 2006 through 2012.  Specifically, this study assesses changes in incidence of HAI, 
prevalence of antimicrobial resistance, and patient-level factors at admission that are associated 





Sample and setting 
Data were collected from four hospitals in a single academically-affiliated network 
located in New York, NY.  The facilities included a 221-bed community hospital, a 283-bed 
pediatric acute care hospital, a 647-bed adult tertiary/quaternary care hospital, and a 914-bed 
adult and pediatric tertiary/quaternary care hospital.  All discharges occurring from January 1, 
2006 through December 31, 2012 were included in the analyses.  Although some patients were 
admitted multiple times throughout the seven-year study period, the unit of analysis for this 
study was each patient discharge. 
Data collection 
 All data were collected retrospectively from the network’s Clinical Data Warehouse, 
which stores information from a variety of electronic sources shared by the four hospitals.49 
Dates of hospital admission and discharge, source of admission, and previous in-network 
hospitalizations were obtained from the admission-discharge-transfer (ADT) record.  Complete 
lists of International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) 
diagnosis and procedure codes associated with each admission were obtained from billing 
records.  Time-stamped culture results and antimicrobial susceptibility patterns were obtained 
from clinical microbiology laboratory records.  All data were linked using patients’ unique 
medical record numbers and admission dates.  The study was approved by the Institutional 
Review Boards of Columbia University Medical Center and Weill-Cornell Medical Center. 
Definitions of infections, antimicrobial resistance, and patient characteristics 
 Four types of commonly occurring HAIs were included in this analysis: BSI, SSI, urinary 




been the target of national and local HAI reduction campaigns.5,8 Algorithms for identifying 
infections in the electronic data were designed in accordance with the NHSN guidelines for 
surveillance of HAI (Figure 2.1).50 The algorithms were created and validated by an 
interdisciplinary team that included an infectious disease physician, and infection prevention 
nurse, an epidemiologist, a database manager, and an IT systems manager with expertise in 
hospital administrative data.49,51,52 Dates of culture collection and hospital admission were used 
to determine whether infections were healthcare-associated, i.e., developed at least two days after 
hospital admission.   
This study included HAI associated with Staphylococcus aureus, Acinetobacter 
baumannii, Streptococcus pneumoniae, Pseudomonas aeruginosa, Klebsiella pneumoniae, 
Enterococcus faecalis and Enterococcus faecium.  Binary classifications of antibiotic resistance 
were defined for S. aureus (oxacillin), S. pneumoniae (penicillin), A. baumannii (ampicillin-
sulbactam), and E. faecalis and E. faecium (vancomycin).  For P. aeruginosa we assessed 
resistance to cefepime, gentamicin, levofloxacin, meropenem, piperacillin/tazobactam, and 
tobramycin.  For K. pneumoniae we assessed resistance to cefepime, ceftriaxone, gentamicin, 
imipenem, levofloxacin, meropenem, piperacillin/tazobactam, tobramycin, and 
trimethoprim/sulfamethoxazole.  Multidrug resistance for P. aeruginosa and K. pneumoniae was 
defined as resistance to at least three antibiotic classes among those assessed.53 Resistance to 
each antibiotic was determined by the hospitals’ clinical microbiology laboratories.  These 
organisms were selected because they have exhibited long-term trends of increasing 
antimicrobial resistance and because they are either endemic to healthcare settings or, in the case 




 Patient characteristics at admission were assessed using several measures.  A weighted 
Charlson Comorbidity Index was created using ICD-9-CM diagnosis codes for conditions 
indicated as being present upon hospital admission.54  Patients who had at least one within-
network inpatient hospitalization in the previous year were identified using ADT records.  In 
addition, ADT records were used to determine patients’ admission source, defined as either 
healthcare (i.e., transfer from another hospital, ambulatory surgery center, skilled nursing 
facility, hospice center) or non-healthcare (e.g., from home).  Patient age, sex, admission 
hospital, and admission year were also collected from the Clinical Data Warehouse. 
Statistical analysis 
 To assess changes in HAI over time we tabulated the number of HAI occurring each year 
and stratified by organism and body site of infection.  Percent changes in HAI incidence per 
10,000 discharges between 2006 and 2012 were calculated.  Multiple logistic regression was 
used to evaluate changes in odds of infection over time, controlling for hospital, age 
(continuous), sex, within-network hospitalization in the previous year, admission source, and 
Charlson Comorbidity Index.  A separate model was constructed for each of the six organisms.  
Patients who had an infection in more than one body site with the same organism during a single 
admission were represented only once in each multivariable model.  In order to evaluate whether 
patient characteristics associated with HAI changed throughout the study period, we also 
assessed interaction between year and age, sex, prior hospitalization, admission source and 
Charlson Comorbidity Index for each body site of infection.   
To assess changes in antibiotic sensitivities over time, we tabulated the annual proportion 
of infections resistant to each of the antibiotics identified a priori for each organism.  Multiple 




for hospital, age, sex, within-network hospitalization in the previous year, admission source, and 
Charlson Comorbidity Index.  Each organism was modeled separately.  Patients who had an 
infection at more than one body site with the same organism during a single admission were 
represented only once in each multivariable model and were considered to have a resistant 
infection if at least one of the infections was caused by a resistant organism.   
 
RESULTS 
Characteristics of the 761,426 patient discharges that occurred during the study period are 
summarized by year in Table 2.1.  A total of 19,052 HAI with the six organisms of interest were 
identified.  Forty-nine percent were UTI (N=9,319), 23% were pneumonia (N=4,414), 19% were 
BSI (N=3,602), and 9% were SSI (N=1,717).  From 2006 to 2012, incidence per 10,000 
discharges fell for each type of HAI (Figure 2.2.a), for each of the six organisms included in this 
study (Figure 2.2.b), and within all four hospitals (Figure 2.2.c).   
Table 2.2 displays results of the multivariable regression analyses modeling the 
association between advancing year and odds of HAI.  For each organism there was a 
statistically significant decrease in the odds of HAI over time, controlling for hospital and patient 
characteristics.  Patients with a healthcare admission source were significantly more likely to 
develop an HAI with all organisms except S. pneumoniae, for which a positive but not 
statistically significant association was found.  Within-network hospitalization in the previous 
year significantly increased the odds of developing an HAI with all organisms except S. 
pneumoniae, for which a statistically significant negative association was found.  Advancing age 
and greater severity of illness were significantly associated with development of HAI for all 




aeruginosa, S. pneumoniae and A. baumannii, while female patients were significantly more 
likely to develop an HAI with K. pneumoniae and E. faecalis/E. faecium.   
As shown in Figures 2.3.a and 2.3.b, the impact of admission source and within-network 
hospitalization in the previous year decreased significantly over time, with the association 
between HAI and previous hospitalization decreasing steadily throughout the study period and 
the association between HAI and admission source decreasing steadily through 2010 and then 
rising again.  Statistically significant interaction with year was not identified for any other factor.   
The annual proportion of HAI caused by antibiotic-resistant organisms is presented in 
Table 2.3.  The multivariable logistic regression analyses show no appreciable change in levels 
of antibiotic resistance for any organism except P. aeruginosa, for which multidrug resistance 
increased significantly over the study period and K. pneumoniae, for which multidrug resistance 
decreased significantly (Table 2.4).  There was a small but statistically significant decrease in 
oxacillin resistance among S. aureus isolates.  Resistance to all tested antibiotics increased for P. 
aeruginosa (Figure 2.4.a).  For K. pneumoniae, resistance decreased slightly for some 
antibiotics but increased sharply for carbapenem, rising from an average of 17 percent in 2006-
2010 to 46 percent in 2011 (Figure 2.4.b).   
Patients with a healthcare admission source were significantly more likely to develop a 
resistant infection for all organisms except S. pneumoniae and A. baumannii.  Resistance was 
significantly associated with within-network hospitalization in the previous year for K. 
pneumoniae, S. aureus, and E. faecalis/E. faecium.  Odds of resistance were significantly higher 
for males among those infected with K. pneumoniae and S. pneumoniae and significantly higher 
for females among those infected with E. faecalis/E. faecium.  There was a small but significant 




faecalis/E. faecium infections.  Advancing age was associated with resistance among S. aureus 
infections, while younger age was associated with resistance among P. aeruginosa infections. 
 
DISCUSSION 
 Using data from four hospitals in a major metropolitan center, we observed persistent and 
statistically significant declines in the incidence of healthcare-associated BSI, SSI, UTI, and 
pneumonia between 2006 and 2012.  The reductions in BSI, SSI, and pneumonia paralleled 
trends tracked at the national level for selected conditions including central line-associated BSI, 
BSI with MRSA, ventilator-associated infections, and SSI following common orthopedic, 
cardiac, gastrointestinal, and gynecological procedures.8,55-57 Though US rates of catheter-
associated UTI climbed in 2009-2012, our study sites continued to experience annual reductions 
of total UTI.8,55   
The reduced incidence of HAI across the study institutions is noteworthy, particularly in 
light of changes to the patient population, which occurred in tandem.  Though severity of illness 
remained stable over the course of the study, the proportion of patients admitted from other 
healthcare facilities and who had been hospitalized in-network within the previous year increased 
considerably, rising from 23 to 45 percent and from 10 to 17 percent, respectively.  Patients who 
have had prolonged contact with the healthcare system tend to be more vulnerable to infection 
and more likely to enter the hospital already having been colonized with common healthcare-
associated pathogens.58 Yet, the observed reductions in HAI were robust despite the 
demographic shift to include a higher burden of these patients.  In fact, the results of the 
interaction models indicate that rates of HAI were falling even more among patients who had 




in HAI may be due, in part, to a reduced risk among this subset.  Improved screening procedures 
for patients admitted from healthcare sources or with known history of hospitalization may have 
contributed to falling HAI rates, possibly because a higher proportion of infections that were 
present upon hospital admission would have been diagnosed within the first 48 hours and 
therefore not counted as HAI, or because interventions such as decolonization were effective at 
preventing HAI.59  Similarly, the slight decrease in S. pneumoniae may be due to faster diagnosis 
and appropriate classification as non-HAI, since these infections are more likely to be acquired 
in the community.  Changes in infection prevention practices at the study institutions such as 
hand hygiene improvement and implementation of a central line care bundle may have 
contributed to declining infection rates overall, though it is difficult to evaluate the impact of 
specific policies since they varied across settings and throughout the course of the study.   
In addition to risk differences between patients with and without previous healthcare 
contact, we also identified risk differences based on gender.  That male patients had higher odds 
of developing HAI caused by S. aureus, P. aeruginosa, S. pneumoniae and A. baumannii while 
female patients had higher odds of K. pneumoniae and E. faecalis/E. faecium may be related to 
the types of infections that these organisms are most likely to cause.  For example, S. aureus is a 
common cause of BSI, which are more common in male patients, and E. faecalis/E. faecium 
have emerged as common causes of UTI, which are more common in female patients.60-62  The 
fact that female patients were more likely to have a vancomycin-resistant strain of E. faecalis/E. 
faecium may be the result of previous antibiotic treatment for recurring UTI.63  S. pneumoniae 
has been reported to occur more frequently among men, possibly due to higher rates of smoking 




treatment for S. pneumoniae and other causes of pneumonia may explain why resistance was 
higher among men.65 
 While the incidence of HAI was greatly reduced, little progress was made with regard to 
reducing antimicrobial resistance.  The strongest trend occurred among P. aeruginosa, for which 
aminoglycoside, carbapenem, cephalosporin, fluoroquinolone, and beta-lactamase inhibitor 
resistance increased.  The proportion of multidrug-resistant P. aeruginosa isolates increased from 
less than one percent in 2006 to over 10 percent in 2012, and statewide data suggest that this 
upward trajectory has continued in recent years.66  For K. pneumoniae we observed moderate 
decreases in resistance to aminoglycoside, cephalosporin, fluoroquinolone, and sulfonamide 
antibiotics as well as increased beta-lactamase activity, though resistance to carbapenems more 
than doubled in 2011 following an outbreak of carbapenem-resistant K. pneumoniae.  It is likely 
that this outbreak contributed to the overall rise in K. pneumoniae infections that occurred in 
2011 after several years of steadily falling rates.  The considerable uptick in carbapenem 
resistance is reflective of a national epidemic of K. pneumoniae carbapenemase, which first 
appeared in New York City in the early 2000s.67,68  Still, the percent of K. pneumoniae isolates 
that were multidrug-resistant was lower than statewide reports of 25 percent and decreased 
throughout the study period.66 This discrepancy may be due to differences in the definition of 
multidrug resistance and the specific drugs for which antimicrobial activity was assessed.  
Similar to trends reported at the state and national levels, methicillin resistance among S. aureus 
remained relatively stable after 2007, following precipitous declines in the previous 
decade.45,48,66,69,70  Consistent with data available from the CDC, no meaningful changes in 
vancomycin resistance among Enterococcus spp. occurred in the study facilities during the 




 This study was conducted during a period of heightened attention toward HAI 
prevention.44 The application of evidence-based practices and bundles coupled with the adoption 
of new reimbursement policies that reframed many healthcare-associated conditions as 
preventable events likely played a role in reducing HAI.71,72  However, since many changes to 
infection prevention practice have been introduced during the last decade, it is not feasible to 
isolate the effects of any single initiative.  Moreover, it is unlikely that any one factor was solely 
responsible for the reduction.73 Analogous broad efforts towards reducing antimicrobial 
resistance among healthcare-associated pathogens were also introduced during this timeframe.  
Antimicrobial stewardship programs may have had some effect with regard to halting the upward 
trends in resistance for many organisms; nonetheless, data suggest that they have not yet had 
much impact with regard to lessening the burden of resistance at the state or national level.48,60,74 
The evidence of such impact is likely to require longer periods of time than other practices 
associated with prevention of HAI. 
 One of the major strengths of this analysis is its application of a consistent methodology 
for identifying HAI over time.  Unlike other sources of longitudinal data, the electronic 
algorithms used to define infections in this study were not sensitive to changes in case 
definitions, infection prevention personnel training, or financial and regulatory incentives that 
may have altered reporting practices.75 Still, the gold standard for diagnosis of an infection is 
clinician adjudication after full chart review, and disadvantages to using electronic data sources 
have been identified.76 The SSI algorithm was designed to include only infections associated 
with NHSN operative procedures, so infections resulting from other procedures were not 
identified. Previous studies have reported low sensitivity for some of the ICD-9-CM codes used 




previous out-of-network hospitalizations were not available, and it is possible that some within-
network hospitalizations were not captured due to erroneous assignment of new medical record 
numbers to patients who were readmitted within one year.  This type of misclassification, 
however, could only lessen the magnitude of the observed association between previous 
admission and odds of HAI.  As the quality and availability of electronic patient data improves, 
the validity of some data elements may have changed over time, though we are not aware of any 
specific changes to the way data were collected or recorded that would have affected the study 
variables.   
In addition to issues of data quality, there are also some limitations to our statistical analyses.  
We were unable to account for previous use of antibiotics, which is a known risk factor for 
resistance and may also confound the associations between infection and prior hospitalization or 
admission from a healthcare source, since patients with previous healthcare contact may be more 
likely to have taken antibiotics.78 In addition, the multivariable model predicting antimicrobial 
resistance for S. pneumoniae was not adequately powered to detect differences over time.  The 
low incidence of healthcare-associated S. pneumoniae throughout the study suggests that 
nosocomial transmission of this pathogen remains relatively rare. 
 Overall, this study provides strong support for the observation that the incidence of HAI 
is falling and that the reduction in HAI is not limited to device- and procedure-associated 
infections.  Although we were unable to measure the impact of any specific policy or practice 
changes due to the overlapping nature of their implementation, the reduction may be the result of 
increased federal and state attention to healthcare quality and patient safety.  Accordingly, 




uptick in national attention towards antimicrobial monitoring and stewardship may precipitate a 












Table 2.1.  Characteristics of hospitalized patients by year 
Year 2006 2007 2008 2009 2010 2011 2012 
N 104,645 106,783 105,177 109,631 112,656 112,122 110,412 
% (no.) admitted to each hospital        
Community 13.1 (13,668) 12.6 (13,476) 12.7 (13,376) 11.7 (12,803) 11.6 (13,072) 11.2 (12,557) 11.1 (12,225) 
Pediatric acute care 15.8 (16,507) 17.1 (18,281) 18.0 (18,959) 15.2 (16,694) 14.6 (16,487) 14.5 (16,260) 14.9 (16,405) 
Adult tertiary/quaternary care 31.9 (33,355) 31.7 (33,839) 31.4 (33,054) 31.9 (35,005) 32.2 (36,283) 31.7 (35,579) 31.3 (34,608) 
Adult/pediatric tertiary/quaternary care 39.3 (41,115) 38.6 (41,187) 37.8 (39,788) 41.2 (45,129) 41.6 (46,814) 42.6 (47,726) 42.7 (47,174) 
% (no.) admitted from healthcare source*  9.6 (10,044) 10.5 (11,228) 10.7 (11,287) 17.3 (18,983) 16.7 (18,798) 17.5 (19,653) 16.6 (18,270) 
% (no.) hospitalized within previous year** 22.6 (23,658) 32.4 (34,601) 37.2 (39,069) 40.2 (44,054) 43.3 (48,772) 44.4 (49,747) 45.1 (49,800) 
Mean (standard deviation) Charlson Comorbidity Index 1.4 (2.75) 1.6 (2.95) 1.6 (2.93) 1.6 (2.99) 1.7 (3.08) 1.8 (3.30) 1.8 (3.36) 
Mean (standard deviation) age in years 44.5 (27.82) 44.3 (27.89) 44.4 (27.99) 44.6 (28.11) 44.8 (28.11) 45.5 (28.3) 45.4 (28.46) 
% (no.) male sex 44.9 (46,989) 44.5 (47,511) 44.2 (46,473) 44.4 (48,717) 44.3 (49,930) 44.5 (49,939) 44.4 (48,989) 
*Admission from another hospital, ambulatory surgery center, skilled nursing facility, or hospice center. 















































N 6,301 4,399 4,116 2,758 688 195 
Year (continuous, 2006-2012) 0.86 [0.85,0.87] 0.89 [0.88,0.90] 0.89 [0.87,0.90] 0.90 [0.88,0.92] 0.88 [0.85,0.92] 0.85 [0.79,0.92] 
Hospital*       
Community 0.44 [0.40,0.48] 0.59 [0.52,0.66] 0.55 [0.49,0.63] 0.49 [0.42,0.56] 0.76 [0.56,1.02] 0.82 [0.49,1.36] 
Pediatric acute care 0.57 [0.51,0.65] 0.70 [0.61,0.79] 1.01 [0.86,1.17] 0.85 [0.71,1.02] 0.78 [0.54,1.13] 0.60 [0.32,1.13] 
Adult/pediatric tertiary/quaternary care  0.54 [0.51,0.57] 0.80 [0.75,0.86] 1.27 [1.20,1.36] 0.80 [0.74,0.87] 1.37 [1.15,1.61] 0.94 [0.69,1.30] 
Healthcare admission source** 2.08 [1.96,2.21] 1.91 [1.78,2.05] 1.88 [1.75,2.02] 2.23 [2.05,2.43] 2.63 [2.23,3.10] 1.39 [0.96,2.00] 
Hospitalized within previous year*** 1.75 [1.66,1.85] 1.47 [1.39,1.57] 1.49 [1.40,1.59] 1.64 [1.52,1.78] 1.39 [1.19,1.63] 0.68 [0.50,0.93] 
Charlson Comorbidity Index 
(continuous) 
1.08 [1.075,1.085] 1.08 [1.07,1.09] 1.08 [1.07,1.09] 1.06 [1.05,1.07] 1.08 [1.07,1.09] 1.08 [1.05,1.11] 
Age in years (continuous)  1.017 [1.016,1.018] 1.009 [1.007,1.010] 1.021 [1.019,1.022] 1.022 [1.020,1.024] 1.01 [1.007,1.014] 1.006 [1.00,1.01] 
Male sex 0.87 [0.83,0.91] 1.57 [1.48,1.67] 0.81 [0.77,0.87] 1.11 [1.03,1.20] 1.42 [1.23,1.65] 1.84 [1.37,2.46] 
Notes:  Results of logistic regression analyses controlling for hospital and patient characteristics.  Data are odds ratios (95% confidence intervals).  N for each organism is less than 
the total incidence for each organism because some patients had infections with the same organism in multiple body sites. 
* Reference: adult tertiary/quaternary care 
**Admission from another hospital, ambulatory surgery center, skilled nursing facility, or hospice center. 



























Table 2.3.  Changes over time in the proportion of healthcare-associated infections resistant to antibiotics, 2006-2012 
 2006 2007 2008 2009 2010 2011 2012 




2006 to 2012 
Enterococcus faecalis and 
Enterococcus faecium 
(N=6,476) 
483/1,120 (43) 529/1,178 (45) 361/927 (39) 406/975 (42) 425/897 (47) 322/763 (42) 279/616 (45) + 5% 
Staphylococcus aureus 
(N=4,553) 
346/735 (47) 395/810 (49) 282/647 (44) 296/679 (44) 295/624 (47) 241/572 (42) 192/486 (40) ̶  15% 
Klebsiella pneumoniae 
(N=4,237) 
69/735 (9) 118/782 (15) 85/633 (13) 29/477 (6) 30/431 (7) 37/570 (7) 43/609 (7) ̶  22% 
Pseudomonas aeruginosa 
(N=2,859) 
3/435 (1) 7/426 (2) 11/479 (2) 35/430 (8) 42/417 (10) 34/361 (9) 33/311 (11) + 1,000% 
Acinetobacter baumannii 
(N=731) 
34/109 (31) 69/144 (48) 69/125 (55) 38/95 (40) 32/81 (40) 40/93 (43) 24/84 (29) ̶  6% 
Streptococcus 
pneumoniae (N=196) 
15/40 (38) 21/43 (49) 19/39 (49) 2/15 (13) 0/12 (0) 10/23 (43) 9/24 (38) 0% 
Total (N=19,052) 950/3,174 (30) 1,139/3,383 (34) 827/2,850 (29) 779/2,671 (29) 824/2,462 (33) 684/2,382 (29) 580/2,130 (27) ̶  10% 
Data are no. resistant isolates/no. total isolates (% resistant).  Antimicrobial resistance was defined as resistance to: oxacillin for Staphylococcus aureus; penicillin for 
Streptococcus pneumoniae; ampicillin-sulbactam for Acinetobacter baumannii; vancomycin for Enterococcus faecalis and Enterococcus faecium; and ≥3 antibiotic classes for 








































N (%) resistant 2,716 (43.1) 1,964 (44.7) 404 (9.8) 165 (5.6) 276 (40.1) 75 (38.5) 
Year (continuous, 2006-2012) 0.98 [0.95,1.01] 0.94 [0.91,0.97] 0.86 [0.82,0.91] 1.45 [1.32,1.59] 0.95 [0.88,1.03] 0.86 [0.73,1.01] 
Hospital*       
Community 0.61 [0.49,0.76] 1.30 [1.03,1.65] 0.63 [0.42,0.95] 0.48 [0.20,1.13] 0.98 [0.52,1.85] 0.88 [0.28,2.76] 
Pediatric acute care 0.40 [0.29,0.55] 1.34 [0.98,1.83] 0.17 [0.09,0.34] 0.34 [0.16,0.74] 0.11 [0.03,0.50] 0.67 [0.16,2.78] 
Adult/pediatric tertiary/quaternary care  2.77 [2.46,3.11] 1.00 [0.87,1.14] 0.37 [0.29,0.47] 0.78 [0.55,1.12] 2.01 [1.42,2.84] 0.74 [0.36,1.53] 
Healthcare admission source** 1.36 [1.21,1.54] 1.28 [1.10,1.48] 1.98 [1.58,2.49] 1.47 [1.04,2.08] 1.05 [0.74,1.49] 2.26 [0.97,5.27] 
Hospitalized within previous year*** 1.46 [1.31,1.63] 1.62 [1.42,1.84] 1.59 [1.28,1.98] 1.18 [0.84,1.66] 0.82 [0.59,1.14] 1.40 [0.70,2.79] 
Charlson Comorbidity Index (continuous) 1.04 [1.03,1.05] 1.01 [1.00,1.03] 1.00 [0.98,1.03] 0.98 [0.94,1.03] 1.00 [0.96,1.04] 1.12 [1.03,1.21] 
Age in years (continuous)  1.002 [0.999,1.005] 1.017 [1.014,1.020] 0.99 [0.98,1.00] 0.98 [0.97,0.99] 1.00 [0.99,1.01] 0.99 [0.97,1.00] 
Male sex 0.84 [0.75,0.93] 0.99 [0.87,1.13] 1.26 [1.02,1.56] 1.08 [0.78,1.49] 1.25 [0.91,1.73] 2.14 [1.11,4.14] 
Notes:  Results of logistic regression analyses controlling for hospital and patient characteristics.  Data are odds ratios (95% confidence intervals).  Antimicrobial resistance was 
defined as resistance to: oxacillin for Staphylococcus aureus; penicillin for Streptococcus pneumoniae; ampicillin-sulbactam for Acinetobacter baumannii; vancomycin for 
Enterococcus faecalis and Enterococcus faecium; and ≥3 antibiotic classes for Pseudomonas aeruginosa and Klebsiella pneumoniae.   
* Reference: adult tertiary/quaternary care 
**Admission from another hospital, ambulatory surgery center, skilled nursing facility, or hospice center. 





Figure 2.1.  Algorithms for identifying four types of infections using electronically available 
data from laboratory records and International Classification of Diseases, 9th Revision, Clinical 
Modification (ICD-9-CM) diagnosis and procedure codes.  Definitions are based on the Centers 
for Disease Control and Prevention National Healthcare Safety Network (NHSN) guidelines for 






















Figure 2.2.a.  Annual incidence of healthcare-associated infections per 10,000 admissions in 
four New York City hospitals by body site, 2006-2012.  The percent decrease in infection rate 













Figure 2.2.b.  Annual incidence of healthcare-associated infections per 10,000 admissions in 
four New York City hospitals by organism, 2006-2012.  The percent decrease in infection rate 





















Figure 2.2.c.  Annual incidence of healthcare-associated infections per 10,000 admissions in 
four New York City hospitals by hospital, 2006-2012.  The percent decrease in infection rate 














Figure 2.3.a.  Changes in association between admission source and healthcare-associated 
infection over time.  Significant interaction between year and admission source in multiple 
logistic regression models controlling for hospital, in-network hospitalization in previous year, 























Figure 2.3.b.  Changes in association between prior in-network hospitalization and healthcare-
associated infection over time.  Significant interaction between year and prior in-network 
hospitalization in multiple logistic regression models controlling for hospital, admission source, 















Figure 2.4.a.  Proportion of Pseudomonas aeruginosa infections resistant to antibiotics in four 
New York City hospitals, 2006-2012.  The percent change in the proportion of resistant isolates 

























Figure 2.4.b.  Proportion of Klebsiella pneumoniae infections resistant to antibiotics in four New 
York City hospitals, 2006-2012.  The percent change in the proportion of resistant isolates 
between 2006 and 2012 is displayed for each antibiotic or class.  Isolates were considered 























Systematic Review of Literature Describing Transmission of Healthcare-associated Infections 
























Pathogens that cause healthcare-associated infections (HAI) are known to survive on 
surfaces and equipment in healthcare environments despite routine cleaning.  As a result, the 
infection status of prior room occupants and roommates may play a role in HAI transmission.  
This systematic review summarizes the literature evaluating the association between patients’ 
exposure to infected/colonized hospital roommates or prior room occupants and their risk of 
infection/colonization with the same organism.  A PubMed search for English articles published 
in 1990-2014 yielded 330 studies which were screened by three reviewers.  Eighteen articles met 
our inclusion criteria. Multiple studies reported positive associations between infection and 
exposure to roommates with influenza and group A Streptococcus, but no associations were 
found for Clostridium difficile, methicillin-resistant Staphylococcus aureus (MRSA), 
Cryptosporidium parvum, or Pseudomonas cepacia; findings were mixed for vancomycin-
resistant enterococci (VRE).  Positive associations were found between infection/colonization 
and exposure to rooms previously occupied by patients with Pseudomonas aeruginosa and 
Acinetobacter baumannii, but no associations were found for resistant Gram-negative organisms; 
findings were mixed for C. difficile, MRSA, and VRE.  Although the majority of studies suggest 
a link between exposure to infected/colonized roommates and prior room occupants, 
methodological improvements such as increasing statistical power and conducting universal 









 Despite decades of infection prevention research and quality improvement initiatives, 
healthcare-associated infections (HAI) remain common adverse events in hospitals and long-
term care facilities.4  Over 700,000 HAIs occur annually in the United States alone, leading to 
death in six percent of cases and costing the healthcare system 28-45 billion U.S. dollars each 
year.9,10,12  Recently there has been renewed interest in understanding the role of the physical 
environment in the spread of HAIs.31,32  Countless studies have reported that pathogenic 
organisms can survive on a variety of fomites in healthcare settings including those at the patient 
bedside (e.g., mattresses, linens, pillows, bedframes, bedrails), inside patient bathrooms (e.g., 
toilets, floors, soap dispensers) and on medical instruments (e.g., blood pressure cuffs, suctioning 
systems).40,79-85  Moreover, the effectiveness of cleaning regimens has been called into question 
as a number of studies have reported that pathogens remain on hospital surfaces even after they 
have been disinfected in accordance with recommended protocols.86-89  Pathogens that survive on 
fomites can subsequently be transferred from contaminated surfaces to patients through direct 
contact, indirect contact via the hands and gloves of healthcare workers, or by aerosolization of 
surface particles.40,82,90-92  
 Patients hospitalized with infections frequently contaminate their surrounding 
environments with pathogenic organisms; therefore, roommates and previous room occupants 
may serve as potential sources of exposure to other patients.20,40  Yet our understanding of how 
such exposures contribute to a patient’s overall risk of infection remains limited, and the effects 
of these exposures may be dependent on a variety of factors unique to each organism species, 
such as their robustness to atmospheric conditions, susceptibility to cleaning agents, and 









 This systematic literature review was performed in accordance with the Preferred 
Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines.93    
Search Strategy 
The literature search was conducted in February 2015.  All databases indexed within 
PubMed were searched using the following combination of keyword and Medical Subject 
Heading (MeSH) search terms linked with Boolean operators:  {[MeSH (Patients’ Rooms)] AND 
[MeSH (Infection Control Practitioners) OR MeSH (Infection Control) OR MeSH (Cross 
Infection) OR MeSH (Infection) OR MeSH (Wound Infection) OR MeSH (Surgical Wound 
Infection) OR Keyword (Infection)]} OR {Keyword (Prior Room Occupant*)} OR {Keyword 
(Roommate) AND [Keyword (Transmission) OR Keyword (Infection*) OR Keyword 
(Outbreak*)]}.  The search was limited to articles published in English from January 1, 1990 
through December 31, 2014.   
Article Selection, Review and Quality Scoring 
Three reviewers independently assessed each article at all stages of the review and 
quality scoring processes.  Discrepancies between reviewers were discussed as a group until a 
consensus was reached.  First, reviewers screened the titles and abstracts of all articles and 
eliminated those that were not relevant to the aims of the review.  The remaining articles 




compared infection and/or colonization rates between patients known to be exposed to infectious 
roommates and/or prior room occupants and patients not known to be exposed; (2) were 
conducted in an acute or long-term healthcare setting; and (3) were original research studies.  
Articles meeting the inclusion criteria were scored according to a modified 20-item version of 
the Checklist for Measuring Study Quality developed by Downs and Black (Table 3.1).94 Some 
measures were not applicable to all articles; these items were removed from the score 
denominator and not assessed for studies in which they were not relevant.  Final scores were 
converted to percentages. 
 
RESULTS 
 Eighteen articles meeting the inclusion criteria were identified (Figure 3.1).  Ten articles 
investigated the effects of exposure to infected or colonized roommates,95-104 six investigated the 
effects of exposure to infected or colonized prior room occupants,105-110 and two investigated 
both exposures.111,112   
Study designs and definitions of exposures and outcomes 
 The articles in this review represent a range of observational and interventional designs 
including retrospective and prospective cohort studies (n=11),96,98-102,105,108-110,112 case-control 
studies (n=4),95,97,103,104 and quasi-experimental studies (n=3).106,107,111 The studies varied 
considerably in their definitions of exposure and outcome measures.  Among studies that 
examined exposure to roommates with non-viral pathogens, four (44%) defined the exposure as 
having a roommate with a clinical infection95-97,112 and five (56%) defined the exposure as 
having a roommate who was either infected or colonized.101-104,111 Among studies that examined 




previous occupant was infectious and in the timeframe during which they occupied the room.  
Four studies (50%) defined the exposure as a previous occupant who was infected or 
colonized,105,108,109,111 two studies (25%)—both of Clostridium difficile—defined the exposure as 
a previous occupant with a history of infection,110,111 and two studies (25%) did not specify.106,107   
 With regard to timing of the exposure, most of the studies implied that only the occupant 
immediately prior to the study subject was included, although only three articles stated this 
explicitly.105,107,110  One study also analyzed exposure to any infectious patient who had occupied 
the same room within the previous two week period.107  Finally, there was notable variation in 
the definition of study outcomes.  Half of the articles used an outcome measure of clinical 
infection95,96,97-100,102,110,112 while the other half used an outcome measure of infection or 
colonization.101,103-109,111  Methods of case detection ranged from universal screening to sampling 
based on clinical indication.   
Findings of studies examining exposure to infected or colonized roommates 
 The twelve articles investigating effects of exposure to infected or colonized roommates 
are described in Table 3.2.a and their findings are summarized in Figure 3.2.a.  Five studies 
evaluated bacterial pathogens that are transmitted via contact.101,103,104,111,112  No significant 
associations between roommate exposure and infection with methicillin-resistant Staphylococcus 
aureus (MRSA), C. difficile, or Pseudomonas cepacia were identified.101,103,112  Results for 
vancomycin resistant enterococci (VRE) were inconsistent, with Bass, et al.111 reporting a 
statistically significant positive association (hazard ratio [HR]: 18.8, 95% confidence interval: 
[5.4-66.2]) and Shorman, et al.104 reporting a statistically significant negative association (odds 




Three studies conducted in long-term care settings examined group A Streptococcus, 
which is transmitted via contact and droplet routes.95,97,102 All three found significant positive 
associations between roommate exposure and infection, with odds ratios (ORs) ranging from 2.0 
[1.1-5.1] to 15.3 [2.5-110.9] (point estimate not reported by Auerbach, et al.95).   
Three studies examined exposure to roommates infected with viral pathogens.98-100  Two 
studies of influenza conducted within the same long-term care facility found significantly 
elevated risks of infection among those with infected roommates (relative risk (RR): 3.1 [1.6-5.8] 
for influenza A and RR: 2.6 [1.2–5.6] for influenza B).98,99  One study evaluated transmission of 
hepatitis C, a viral bloodborne pathogen, in a liver transplant ward of an acute care hospital and 
found significantly increased odds of infection after sharing a room with an infected patient (OR: 
12.0 [1.4-103.0]).100  One parasitic pathogen spread via fecal-oral contact, Cryptosporidium 
parvum, was evaluated in an acute care Human Immunodeficiency Virus (HIV) ward and no 
association was found.96   
Findings of studies examining exposure to rooms previously occupied by infected or colonized 
patients 
The eight articles investigating the effects of exposure to rooms previously occupied by 
infected or colonized patients are described in Table 3.2.b. and their findings are summarized in 
Figure 3.2.b.  All of the articles studied bacterial pathogens spread through contact transmission 
in acute care hospitals, with all but two111,112 taking place in intensive care units (ICUs).  Nsier, 
et al.,109 found that exposure to rooms previously occupied by patients with Acinetobacter 
baumannii and Pseudomonas aeruginosa resulted in significantly higher odds of infection or 
colonization (OR: 4.2 [2.0-8.8] and OR: 2.3 [1.2-4.3], respectively), while the two studies that 




association.105,109  Effects of exposure to rooms previously occupied by patients with C. difficile, 
MRSA, and VRE were examined by at least two studies each.  For each of these organisms, 
significant positive associations were reported by one article (C. difficile, HR: 2.4 [1.2 - 4.5];40 
MRSA, OR: 1.4 (p=0.04);106 VRE, HR: 3.8 [2.0-7.4]107), with the remainder of articles reporting 
no significant associations.108,111,112   
Quality of included articles  
 Quality scores ranged from 50 to 95%, with the majority of articles scoring at or above 
80% (median=83%, mean=82%).  Table 3.1 provides a summary of scores for each item.  All of 
the articles had clearly stated aims, adequate descriptions of study populations, appropriate 
control groups, and acceptable reporting of results.  However, many of the studies did not 
appropriately control for confounding (50%, n=9), address differential follow-up between 
exposed and unexposed patients (33%, n=6), or use acceptable statistical methods (17%, n=3).  
In addition, some articles did not include sufficient or precise definitions of the exposures (17%, 
n=3) or outcomes (6%, n=1) under investigation.  Notably, none of the articles reported a sample 
size calculation indicating adequate power to detect differences between patients exposed versus 
unexposed to infected/colonized roommates or prior room occupants. 
 
DISCUSSION 
 More than half of the articles identified in this systematic literature review reported at 
least one statistically significant positive association between the infection/colonization status of 
a roommate or previous room occupant and the development of HAIs.95,97-100,102,106,107,109-111  
Only a single article identified a statistically significant negative association.104  The remainder 




they were insufficiently powered; none of the articles reviewed included a statement indicating 
that statistical power was adequate for the analyses presented.  Another factor which may have 
contributed to findings of no association is that many studies included patients who were either 
infected or colonized as potential sources of exposure.  Patients with symptomatic infections may 
shed greater amounts of infectious body fluids to surrounding fomites compared with patients 
who are asymptomatically colonized.113 Therefore, if a causal association does indeed exist, 
including both infected and colonized patients as potential sources of exposure may have driven 
findings toward the null, since exposure to colonized roommates and prior room occupants could 
present less risk to patients.  Heterogeneity of the exposure may have also arisen from variation 
in the infection or colonization site of a roommate or prior room occupant. In a study of patients 
with MRSA, environmental contamination was more prevalent on fomites surrounding patients 
with positive wound or urine cultures compared with patients who had positive blood or sputum 
cultures.40  
 The studies we reviewed revealed consistent findings for some pathogens (influenza, 
group A Streptococcus) and inconsistent findings for others (VRE, MRSA, C. difficile).  For 
endemic healthcare pathogens such as VRE, MRSA, and C. difficile, it may be difficult to isolate 
the effects of roommates and previous room occupants since the exposure and outcome are 
common and may originate from multiple sources.47  On the contrary, pathogens such as 
influenza and group A Streptococcus are more commonly associated with outbreak scenarios, 
making it easier to single out the effects of particular exposures.114  Other factors which may 
have contributed to inconsistent findings across studies are variations in how exposures and 
outcomes were defined and operationalized (e.g., differences in case definitions, case finding 




While the inconsistency of findings for some of the organisms could be due to artifact, 
there may nevertheless be real differences in the effects of roommate and prior room occupant 
exposure based on biological characteristics of the infecting species.  Microorganisms vary in 
their abilities to produce spores and survive changes to atmospheric temperature and moisture 
conditions.39  In addition, some organisms favor specific sites of colonization or infection that 
may produce greater shedding of infectious material and higher potential for environmental 
contamination.39  For example, a study of multidrug resistant pathogens found that 
environmental contamination was more common surrounding patients with gram-positive versus 
gram-negative infections.20 Furthermore, organism species differ in their resiliency to withstand 
cleaning agents and methods.115,116 
The preponderance of evidence presented in this review suggests that there is a link 
between exposure to infected or colonized roommates and previous room occupants and the risk 
of HAIs.  These findings present a number of practice and policy implications.  First, the fact that 
patient rooms may serve as a reservoir for pathogens deposited by roommates and previous 
occupants highlights the importance of proper hand hygiene, not just for staff but for competent 
patients and their visitors as well.117  To underscore this point, a molecular typing study 
demonstrated that 12% of patients who became newly colonized with MRSA while in the ICU 
acquired a strain that most probably came from contamination in their immediate environment.84  
Second, these results emphasize the need for improved cleaning and disinfection of patient 
rooms, both during patients’ hospital stays and upon their discharge.  For patients with known 
infection or colonization, targeted daily and terminal cleaning procedures that are tailored to 
specific organisms may reduce environmental contamination and infection rates.118 Enhancement 




or colonization, however, since patients may contaminate their environments during incubation 
periods before infections are detected or when colonization is not detected through active 
surveillance. 
There were some limitations to this systematic review.  It is possible that some studies 
that would have met the inclusion criteria were not identified, and that some studies are missing 
from the literature due to publication bias.  Our restriction to articles published in English may 
have also excluded some relevant papers.  Lastly, while a major strength of this study is its 
coverage of two and a half decades of literature, changes in the epidemiology of HAIs, infection 
control policies and procedures, and study methodology over time may have introduced some 
variability to the studies we reviewed. 
Notwithstanding these limitations, it is notable that the studies reporting significant 
findings were conducted across a range of institutions in several different countries across 
multiple decades.  Presumably, the diverse study facilities employed a variety of cleaning 
products, methods, and infection control policies.  Despite possible variations in practice, 












1. Is the hypothesis/aim/objective of the study clearly described?   
Population, intervention or exposure, and outcome included?  Yes=1; No=0.   
Note: Score may be based on study’s main aim.   
18 (100%) 0 0 0 
2. Are the main outcomes to be measured clearly described in the introduction or methods 
section?  Enough information provided to replicate study?  Yes=1; No=0. 
17 (94%) 
 1 (6%) 0 0 
3. Are the characteristics of the patients included in the study clearly described?   
General patient population and inclusion/exclusion criteria described?  Yes=1; No=0.   
Note: Descriptive statistics not required. 
18 (100%) 0 0 0 
4. Is exposure of interest clearly described? Enough information provided to replicate study?  
Yes=1; No=0.  Note: Score based on exposure of interest (i.e., prior room occupant and/or 
roommate infection status). 
15 (83%) 3 (17%) 0 0 
5. Are the distributions of principal confounders in each group of subjects to be compared 
clearly described?  Most clinically relevant characteristics described=2; Only a few general 
patient characteristics described=1; No characteristics described=0. 
Most described: 13 (72%) 
Few described: 3 (17%) 0 0 0 
6. Are the main findings of the study clearly described?   
Results presented for all proposed analyses and outcome measures?  Yes=1; No=0. 18 (100%) 0 0 0 
7. Does the study provide estimates of the random variability in the data for the main 
outcomes?  Confidence intervals, p-values, or other measures of standard error included?  
Yes=1; No=0.  Note: Score based on analyses for roommate and/or prior room occupant 
exposures. 
18 (100%) 0 0 0 
8. Have the characteristics of patients lost to follow-up been described?   
If loss to follow-up is implied, are patients described or compared to those who participated?  
Yes=1; No=0.  Note: If loss to follow-up not mentioned by authors, item scored as “not 
applicable” and removed from denominator.   
2 (11%) 
 0 0 16 (89%) 
9. Have actual probability values been reported for the main outcomes except where p< 
0.001?  Yes=1; No=0.   18 (100%) 0 0 0 
10. Were patients selected in a way that is representative of the source population the 
authors identified in the inclusion/exclusion criteria?   
All patients identified in source population included=1; Certain patients included in source 
population systematically excluded (e.g., patients who died, were transferred, refused 
participation, etc.)=0.  Note:  Zero was scored if authors did not provide enough information to 
determine representativeness. 
16 (89%) 
 0 2 (11%) 0 
11. Were the staff, places, and facilities where the patients were treated, representative of 
the treatment the majority of patients receive?  Facility similar to other institutions of the 
same type?  Yes=1; No=0.  Note:  Zero was scored if authors did not provide enough 
information to determine representativeness. 
17 (94%) 
 0 1 (6%) 0 
12. If any of the results of the study were based on “data dredging”, was this made clear?    
All sub-group analyses described in methods section or noted as post-hoc analyses=1; 
Unplanned sub-group analyses presented and not noted as post-hoc=0.  Note:  If study included 
no sub-group analyses, item scored as “not applicable” and removed from denominator.   





13. Do the analyses adjust for different lengths of follow-up of patients, or in case-control 
studies, is the time period between the intervention and outcome the same for cases and 
controls?  If follow-up is differential between groups, was this controlled for in the design or 
analysis?  Yes=1; No=0.  Note:  If follow-up is same for all patients, item scored as “not 
applicable” and removed from denominator.   
8 (44%) 6 (33%) 0 4 (22%) 
14. Were the statistical tests used to assess the main outcomes appropriate?   
Statistical tests minimally appropriate for the data and research questions? Yes=1; No=0. 15 (83%) 3 (17%) 0 0 
15. Were the main outcome measures used valid and reliable?   
Systematic, repeatable methods of case finding and appropriate lab definitions used?  Yes=1; 
No=0.  Note:  Zero was scored if authors did not provide enough information to assess outcome 
measures. 
16 (89%) 1 (6%) 0 1 (6%) 
16. Were the patients in different intervention groups or cases and controls recruited from 
the same population?  Yes=1; No=0. 18 (100%) 0 0 0 
17. Were study subjects in different intervention groups or cases and controls recruited 
over the same period of time?  Yes=1; No=0. 18 (100%) 0 0 0 
18. Was there adequate adjustment for confounding in the analyses from which the main 
findings were drawn?  Key confounders included in multivariable models?  Yes=1; No=0.   
Note: Score based on exposure of interest (i.e., prior room occupant and/or roommate infection 
status). 
9 (50%) 6 (33%) 3 (17%) 0 
19. Were losses of patients to follow-up taken into account?   
If loss to follow-up is reported, is an appropriate statistical method used to account for this?  
Yes=1; No=0.  Note: If no loss to follow-up is reported, item scored as “not applicable” and 
removed from denominator.  Zero was scored if authors did not provide enough information to 
assess loss to follow-up. 
1 (6%) 1 (6%) 16 (89%) 0 
20. Did the study have sufficient power to detect a clinically important effect where the 
probability value for a difference being due to chance is less than 5%?   
Power calculation included and adequate power reported=1; Power calculation included and 
inadequate power reported or no power calculation mentioned=0.  Note: Score based on 
exposure of interest (i.e., prior room occupant and/or roommate infection status).  Zero was 
scored if authors did not provide enough information to assess power. 
0 4 (22%) 14 (78%) 0 
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Unadjusted OR OR: 0.04 [0.004 -0.4] 
BMI, body mass index; C. difficile, Clostridium difficile; CF, cystic fibrosis; CHF, congestive heart failure; GAS, Group A Streptococcus; HCV, hepatitis C virus; HR, hazard 
ratio; LOS, length of stay; MRSA, methicillin-resistant Staphylococcus aureus; OR, odds ratio; P. cepacia, Pseudomonas cepacia; PVD, peripheral vascular disease; RR, relative 
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Figure 3.1.  Identification, screening, eligibility, and inclusion of articles according to the 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.  
Three hundred and thirty articles were identified via the database search and no additional 

























Figure 3.2.a.  Findings of studies investigating the association between healthcare-associated 
infection or colonization and exposure to infected or colonized roommates.  Studies reporting 
significant positive associations are represented in black circles and studies reporting significant 
negative associations are represented in white circles.  Studies which did not find statistically 























Figure 3.2.b.  Findings of studies investigating the association between healthcare-associated 
infection or colonization and exposure to infected or colonized prior room occupants.  Studies 
reporting significant positive associations are represented in black circles.  Studies which did not 
find statistically significant associations are represented in gray circles.  No studies reported a 































Case Control Study of the Association between Exposure to Roommates or Prior Bed Occupants 

























Patients who are infected or colonized by pathogenic bacteria are known to contaminate surfaces 
and equipment in hospital rooms, yet little is understood about the risk this poses to subsequent 
bed occupants or concurrent roommates.  The objective of this matched case-control study was 
to quantify the association between having a prior bed occupant or roommate with a positive 
blood, respiratory, urine, or wound culture and subsequent infection with the same organism.  
The study was conducted in four New York City hospitals: a 221-bed community hospital, a 
283-bed pediatric acute care hospital, a 647-bed adult tertiary/quaternary care hospital, and a 
914-bed pediatric and adult tertiary/quaternary care hospital.  Cases included all inpatients 
discharged January 1, 2006 through December 31, 2012 who developed a healthcare-associated 
infection (HAI) with Staphylococcus aureus, Acinetobacter baumannii, Streptococcus 
pneumoniae, Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterococcus faecalis, or 
Enterococcus faecium.  Controls were uninfected patients matched by fiscal quarter, hospital and 
length of stay.  For each bed a case occupied during the 3-5 day period prior to infection, all 
microbiology results for (1) the patient who occupied the bed immediately prior to the case and 
(2) all assigned roommates were collected.  The same process was applied for controls, with the 
matched case’s day of infection serving as the reference point.  HAIs were identified using 
standardized national surveillance definitions applied to electronic health records.  A total of 
10,289 HAIs were identified among 761,426 admissions.  In a multivariable analysis controlling 
for patient characteristics and mutually controlling for each exposure, odds of being exposed to a 
prior bed occupant with the same organism were 5.83 (95% Confidence Interval [3.62, 9.39]) 
times greater for cases versus controls and the odds of being exposed to a roommate with the 




deadly.  The results of this study indicate that some HAIs may be preventable through the use of 
enhanced terminal cleaning procedures or products and intermittent cleaning protocols designed 


























Over 700,000 healthcare-associated infections (HAIs) occur in US hospitals each year.10 
These infections—considered to be largely preventable—accrue $28-45 billion annually in 
excess healthcare costs and are fatal in nearly 6 percent of cases.9,12,119 Efforts to improve quality 
of care while reducing costs have made HAI prevention a national priority and sparked a surge of 
innovative measures aimed at curtailing their spread.18,120 Many of these interventions have 
specifically targeted high-risk patients with protocols for the care and maintenance of indwelling 
devices, with measurable but varied success.121  
Meanwhile, a growing body of evidence demonstrating widespread contamination of 
hospital rooms and equipment has led to increasing concern about the risks posed to patients by 
current cleanliness standards and practices.38 A deluge of new products are being developed and 
marketed to hospitals for the purpose of improving environmental disinfection, with particular 
attention paid to routine cleaning for patients with multidrug-resistant organisms and terminal 
cleaning after discharge.122 However, very few studies have examined whether there is a link 
between contamination in patient rooms and risk of infection. Given the constraints of financial 
and human resources for infection prevention and control, it is important to quantify the potential 
impact of enhanced environmental cleanliness. Our study addressed this question by evaluating 
whether there is an association between HAIs and exposure to infected or colonized hospital 








 This study was conducted in four inpatient hospitals located in New York City. The 
hospitals, all part of the same healthcare network, included a community hospital (221 beds), a 
pediatric acute care hospital (283 beds), an adult tertiary/quaternary care hospital (647 beds), and 
a pediatric and adult tertiary/quaternary care hospital (914 beds). All patients discharged during 
the period of January 1, 2006 through December 31, 2012 were eligible for inclusion. 
Data Collection  
 All study data were collected retrospectively. Data were sourced from multiple electronic 
systems used for clinical documentation and administrative purposes throughout the hospital 
network and linked using unique medical record numbers and dates of admission and 
discharge.49 Demographic information and patient characteristics were sourced from 
administrative data and included age, sex, risk of mortality as measured by the Charlson 
Comorbidity Index,54 and specific comorbid conditions including malignancies, renal failure, and 
diabetes. International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-
CM) codes were used to create the Charlson Comorbidity Index and identify comorbid 
conditions. Patients’ room and bed assignments for each day of hospitalization were collected 
from the admission-discharge-transfer system. Culture results and antimicrobial susceptibility 
data including date and site of culture collection were obtained from clinical microbiology 
records. 
Study Design 
A matched case-control design was used to evaluate the association between having a 
prior bed occupant or roommate with a positive blood, respiratory, urine, or wound culture and 
subsequent infection with the same organism and comparable antibiotic sensitivity profile. Cases 




tract infection (UTI), surgical site infection (SSI), or pneumonia with one of the following 
organisms: oxacillin-sensitive Staphylococcus aureus, oxacillin-resistant S. aureus, ampicillin-
sulbactam-sensitive Acinetobacter baumannii, ampicillin-sulbactam-resistant A. baumannii, 
penicillin-sensitive Streptococcus pneumonia, penicillin-resistant S. pneumonia, levofloxacin-
sensitive Pseudomonas aeruginosa, levofloxacin-resistant P. aeruginosa, imipenem-sensitive 
Klebsiella pneumoniae, imipenem-resistant Klebsiella pneumoniae, vancomycin-sensitive 
Enterococcus faecalis and E. faecium and vancomycin-resistant E. faecalis and E. faecium. HAIs 
were detected via electronic algorithms analogous to the Centers for Disease Control and 
Prevention National Healthcare Safety Network surveillance definitions (Figure 2.1).49,50 The 
included infection types were selected due to their high incidence in healthcare settings and 
because they have been specifically targeted by national and local HAI reduction campaigns.5,8  
Organisms were selected due to their high prevalence in healthcare settings and concerning trend 
towards increasing antimicrobial resistance.8,9 
Controls were matched to cases in a 1:1 ratio and were randomly selected from all 
patients who: (1) never had a positive culture with the organism under investigation during their 
hospitalization; (2) were admitted during the same fiscal quarter as the case; (3) were admitted to 
the same hospital as the case; (4) had a length of stay at least as long as the case’s length of stay 
prior to infection.  
Exposure to prior bed occupant 
All beds that each case occupied during the 3-5 day period prior to infection were 
identified using a computerized algorithm.  For each of these beds, a second algorithm was 
applied to identify the patient who occupied the bed immediately prior to the case.  A third 




the previous occupants had a positive culture with the organism of interest at any point prior to 
being discharged from the bed they occupied prior to the case.  The same process was applied for 
controls, with the matched case’s day of infection serving as the reference point.  For example, if 
the matched case had an infection on day 10, we looked back 3-5 days from day 10 of the 
control’s hospital stay. 
Exposure to hospital roommate   
All rooms that each case occupied during the 3-5 day period prior to infection were 
identified using a computerized algorithm.  For each of these rooms, a second algorithm was 
applied to identify any other patients assigned on the same date(s) as the case.  A third algorithm 
was used to search the clinical microbiology data to determine whether or not any of the 
roommates had a positive culture with the organism of interest at any point prior to sharing a 
room with the case.  The same process was applied for controls, with the matched case’s day of 
infection serving as the reference point.   
Data Analysis 
Bivariate comparisons between cases and controls with respect to exposure to infected or 
colonized prior room occupants, exposure to infected or colonized roommates, age, Charlson 
Comorbidity Index, sex, presence of malignancies, renal failure, and diabetes mellitus were 
conducted within each organism category using chi-square tests for independence, Fisher’s exact 
tests, or two-sample t-tests, as appropriate.  The total numbers and proportions of cases and 
controls exposed to infected or colonized prior room occupants and roommates were tabulated to 
determine crude odds ratios (OR) and 95% confidence intervals (CI).  Multivariable logistic 
regression analysis was performed to calculate adjusted odds ratios mutually controlling for both 




To determine with greater certainty whether a prior occupant or roommate was the source 
of exposure, we compared isolates for a sample of exposed case-roommate and case-prior 
occupant pairs.  Since molecular typing of isolates was not available, we compared antimicrobial 
susceptibilities based on available antimicrobial susceptibility data.  K. pneumoniae was selected 
for this sub-analysis due to the range of antibiotics tested for this organism in the study 
institutions.  The tested antibiotics included cefepime, ceftriaxone, gentamicin, imipenem, 
levofloxacin, meropenem, piperacillin-tazobactam, tobramycin, and trimethoprim.   
 
RESULTS 
Patient admissions across the four facilities totaled 761,426 during the study period. 
There were 10,289 HAIs identified and eligible controls were available for 10,033 (97.5%). 
Table 4.1 displays bivariate comparisons between cases and controls with respect to 
demographic characteristics, comorbid conditions, and exposure to infected or colonized 
roommates and prior bed occupants by organism.  A total of 136 cases were exposed to a prior 
bed occupant with the same organism compared with 20 controls (crude OR [95% CI]: 6.88 
[4.30, 11.01]).  A total of 309 cases were exposed to a roommate with the same organism 
compared with 64 controls (crude OR [95% CI]: 4.95 [3.78, 6.49]).  Fewer than two percent of 
cases were exposed to a previous bed occupant with the same organism and fewer than four 
percent were exposed to roommates with the same organism (Figure 4.1).  In the multivariable 
analysis controlling for patient characteristics and mutually controlling for each exposure, the 
odds of being exposed to a prior bed occupant with the same organism were 5.83 [3.62, 9.39] 
times greater for cases versus controls and the odds of being exposed to a roommate with the 




In the K. pneumoniae sub-analysis comparing antibiotic sensitivity of case isolates with 
roommate isolates, antimicrobial susceptibility data were available for 38 of 43 exposed case-
roommate pairs.  Of those, 22 pairs (58%) had identical susceptibility profiles.  Notably, among 
the remaining 16 pairs, most (n=11, 69%) displayed additional antibiotic resistance in the case 
isolate, leaving open the possibility that resistance was acquired during the roommate’s course of 
treatment and the more resistant isolate was passed on to the case.  The unadjusted OR [95% CI] 
was 1.6 [0.80, 3.10] after limiting the cases to pairs with identical susceptibility profiles and 2.02 
[1.06, 3.84] when limiting the cases to pairs with identical susceptibility profiles or additional 
resistance in the case.  For prior room occupant pairs, susceptibility data were available for 20 of 
27 pairs and of those, 11 (55%) had identical susceptibility profiles.  Among the remaining nine 
pairs, six (67%) displayed additional antibiotic resistance in the case isolate.  The unadjusted OR 
[95% CI] was 5.5 [1.22, 24.98] after limiting the cases to pairs with identical susceptibility 
profiles and 8.58 [1.98, 37.17] when limiting the cases to pairs with identical susceptibility 
profiles or additional resistance in the case. 
 
DISCUSSION 
 The long campaign towards improving patient safety and reducing preventable deaths in 
hospitals has had many successes.123,124  Still, too many Americans continue to die unnecessarily 
from infections they contract while in the hospital.119  The need to focus on prevention is 
evermore acute with the proliferation of multidrug resistant organisms and increasingly limited 
options for successful treatment.124   
 The good news is that we now have strong evidence that interventions designed to 




randomized controlled trial to determine the efficacy of enhanced terminal cleaning procedures 
for patients with multidrug resistant organisms was recently published.  This study of nine 
hospitals showed a statistically significant decrease in organism acquisition when targeted 
cleaning methods—particularly ultraviolet light technology—were incorporated into the standard 
cleaning protocol, adding only four extra minutes to the total cleaning time.126   
As the largest study to quantify the association between HAIs and exposure to infected or 
colonized previous bed occupants and roommates, encompassing data from all inpatient units in 
four acute care hospitals and surveying exposure to six different organisms, our analysis serves 
to illustrate how many infections might be prevented by implementing enhanced cleaning 
measures.  Previous studies have reported mixed findings due to wide variations in sample size, 
study quality, design, patient population, and definitions of exposures and outcomes, though the 
majority did find statistically significant relationships between at least one of their exposures and 
outcomes of interest.127 Our findings revealed robust and statistically significant associations, 
with exposure to an infected or colonized prior bed occupant conferring a nearly six-fold 
increase in the odds of infection, and exposure to an infected or colonized roommate conferring a 
nearly five-fold increase.  It is possible that these results actually underestimate the true 
association, since by limiting the look-back period to the most likely period of exposure—three 
to five days prior to infection—we only captured a portion of roommates and prior room 
occupants who could have been sources of exposure.50 
     The primary limitation of this study was the unavailability of molecular typing, which 
made it impossible to determine with certainty whether a case acquired a pathogen genetically 
identical to that of the roommate or prior occupant presumed to be the source of exposure.  




and roommates remains plausible for two reasons.  First, we performed a sub-analysis to assess 
whether or not isolates were phenotypically similar with regard to their susceptibility to a variety 
of antibiotic agents and still found statistically significant associations between prior bed 
occupant or roommate exposure and the development of HAIs.  Furthermore, in the majority of 
cases where antibiotic sensitivity did differ, resistance was more prevalent among the cases than 
among the prior occupants or roommates presumed sources of exposure.  This supports the 
possibility that resistance was acquired during the roommate or prior occupant’s antibiotic 
therapy, and the resistant organism was passed to the case. Second, the epidemiological 
association we identified remained sizeable and highly significant even after controlling for a 
number of potential confounders. It is possible that the association could be due to an unknown 
confounder that we were unable to identify or measure in this retrospective study.  For example, 
if certain rooms were reserved for the highest risk patients, patients assigned to such rooms could 
have both a higher risk of exposure due to their room placement as well as a higher risk of 
infection due to their condition upon admission to the unit.  This is especially true for single 
rooms, which are frequently used for isolation and thus may have greater bioburden.  Indeed, 
there were some statistically significant differences between cases and controls at baseline with 
regard to the comorbid conditions that affect infection risk.  However, the associations remained 
robust in the multivariable model controlling for these variables, suggesting that confounding by 
factors related to patient severity of illness was minimal, if present at all.  Lastly, though all in-
network culture results prior to room assignment were known, it is possible that some roommate 
pairs were cohorted based on reports of colonization or infection from other institutions at the 




  The human and financial costs associated with HAIs are unacceptably high and may 
continue to grow along with antimicrobial resistance and the shortage of novel therapies on the 
immediate horizon.125 In light of mounting evidence that (1) patients harboring pathogens do 
contaminate their hospital rooms,128 (2) current standards for cleaning and disinfection are not 
sufficient for decontamination,129 and (3) exposure to contaminated rooms confers a five- to six-






Table 4.1. Bivariate comparisons between cases and controls with respect to demographic characteristics, comorbid conditions, and exposure to infected or colonized roommates 
and prior bed occupants 
 Sensitive isolates Resistant isolates 
 Cases Controls P-value Cases Controls P-value 
Acinetobacter baumannii N=258 N=258  N=214 N=214  
Infected or colonized prior occupant 3 (1.1) 0 (0) 0.25 6 (2.8) 0 (0) 0.01 
Infected or colonized roommate 3 (1.1) 0 (0) 0.25 16 (7.5) 1 (0.5) <0.001 
Age  54.6 (25.6) 54.2 (25.8) 0.84 46.6 (30.3) 47.5 (30.8) 0.74 
Charlson Comorbidity Index  5.9 (5.2) 4.9 (4.8) 0.02 3.7 (5.5) 3.7 (4.1) 0.97 
Female 113 (43.8) 126 (48.8) 0.25 116 (54.2) 116 (54.2) 1.00 
Malignancies 51 (19.8) 30 (11.6) 0.01 20 (9.4) 27 (12.6) 0.28 
Renal failure 93 (36.1) 59 (22.9) 0.001 24 (11.2) 18 (8.4) 0.33 
Diabetes mellitus 61 (23.6) 53 (20.5) 0.40 36 (16.8) 37 (17.3) 0.90 
Enterococci N=1,259 N=1,259  N=1,238 N=1,238  
Infected or colonized prior occupant 13 (1.0) 2 (0.2) 0.004 28 (2.3) 2 (0.2) <0.001 
Infected or colonized roommate 32 (2.5) 3 (0.2) <0.001 25 (2.0) 5 (0.4) <0.001 
Age  54.5 (25.3) 52.9 (26.3) 0.10 60.0 (19.1) 56.6 (24.1) <0.001 
Charlson Comorbidity Index  5.7 (6.0) 4.9 (5.2) <0.001 6.7 (4.4) 5.3 (5.6) <0.001 
Female 559 (44.4) 523 (41.5) 0.15 579 (46.8) 570 (46.0) 0.72 
Malignancies 264 (20.1) 210 (16.7) 0.006 417 (33.7) 191 (15.4) <0.001 
Renal failure 343 (27.2) 258 (20.5) <0.001 457 (36.9) 310 (25.0) <0.001 
Diabetes mellitus 313 (24.9) 259 (20.6) 0.01 296 (23.9) 285 (23.0) 0.60 
Klebsiella pneumoniae N=1,091 N=1,091  N=629 N=629  
Infected or colonized prior occupant 20 (1.8) 1 (0.1) <0.001 7 (1.1) 1 (0.2) 0.07 
Infected or colonized roommate 36 (3.3) 11 (1.0) <0.001 7 (1.1) 3 (0.5) 0.34 
Age  55.8 (25.4) 52.1 (27.1) 0.001 57.4 (22.9) 55.1 (25.2) 0.09 
Charlson Comorbidity Index  6.4 (5.4) 4.4 (4.0) 0.001 6.6 (5.0) 5.0 (5.2) <0.001 
Female 508 (46.6) 501 (45.9) 0.76 292 (46.4) 283 (45.0) 0.61 
Malignancies 340 (31.2) 143 (13.1) <0.001 151 (24.0) 88 (14.0) <0.001 
Renal failure 324 (29.7) 214 (19.6) <0.001 228 (36.3) 136 (21.6) <0.001 
Diabetes mellitus 234 (21.5) 216 (19.8) 0.34 165 (26.2) 135 (21.5) 0.047 
Pseudomonas aeruginosa N=1,027 N=1,027  N=500 N=500  
Infected or colonized prior occupant 11 (1.1) 0 (0) <0.001 1 (0.2) 0 (0) 0.999 
Infected or colonized roommate 51 (5.0) 6 (0.6) <0.001 11 (2.2) 1 (0.2) 0.006 
Age  57.6 (25.1) 53.7 (25.4) <0.001 58.9 (22.8) 57.4 (23.2) 0.33 
Charlson Comorbidity Index  6.1 (4.7) 4.8 (4.7) <0.001 5.6 (4.1) 5.2 (4.5) 0.10 
Female 474 (46.2) 462 (54.0) 0.60 236 (47.2) 232 (46.4) 0.80 
Malignancies 219 (21.3) 144 (14.0) <0.001 76 (15.2) 62 (12.4) 0.20 
Renal failure 277 (27.0) 221 (21.5) 0.004 157 (31.4) 109 (21.8) <0.001 
Diabetes mellitus 244 (23.8) 200 (19.5) 0.02 138 (27.6) 123 (24.6) 0.28 
Staphylococcus aureus N=2,008 N=2,008  N=1,632 N=1,632  
Infected or colonized prior occupant 21 (1.1) 9 (0.5) 0.03 26 (1.6) 5 (3.5) <0.001 
Infected or colonized roommate 81 (4.0) 25 (1.3) <0.001 46 (2.8) 9 (0.6) <0.001 
Age  50.8 (25.8) 52.0 (26.6) 0.15 60.5 (22.4) 56.1 (24.3) <0.001 





Female 824 (41.0) 873 (43.5) 0.12 678 (41.5) 731 (44.8) 0.06 
Malignancies 335 (16.7) 223 (11.1) <0.001 309 (18.9) 207 (12.7) <0.001 
Renal failure 475 (23.7) 394 (19.6) 0.002 564 (34.6) 351 (21.5) <0.001 
Diabetes mellitus 443 (22.1) 445 (22.2) 0.94 459 (28.1) 361 (22.1) <0.001 
Streptococcus pneumoniae N=107 N=107  N=70 N=70  
Infected or colonized prior occupant 0 (0) 0 (0) N/A 0 (0) 0 (0) N/A 
Infected or colonized roommate 0 (0) 0 (0) N/A 1 (1.4) 0 (0) 0.999 
Age  55.6 (23.4) 56.7 (26.6) 0.75 49.9 (23.2) 50.2 (28.4) 0.94 
Charlson Comorbidity Index  4.8 (4.1) 5.6 (4.5) 0.27 5.8 (5.6) 3.9 (3.6) 0.02 
Female 44 (41.1) 44 (44.1) 1.00 20 (28.6) 29 (41.4) 0.11 
Malignancies 17 (15.9) 13 (12.2) 0.43 13 (18.6) 0 (0) <0.001 
Renal failure 26 (24.3) 26 (24.3) 1.00 14 (20.0) 12 (17.1) 0.66 
Diabetes mellitus 19 (17.8) 18 (16.8) 0.86 15 (21.4) 12 (17.1) 0.52 
Categorical variables are frequency (percent) with bivariate comparisons conducted using chi-square test for independence or Fisher’s exact test.  Continuous variables are mean 



































Table 4.2.  Association between exposure to infected or colonized prior bed occupants and roommates 
Exposure Odds Ratio [95% Confidence Interval] 
Exposure to infected or colonized prior occupant 5.83 [3.62, 9.39] 
Exposure to infected or colonized roommate 4.82 [3.67, 6.34] 
Age in years 1.00 [0.999, 1.001] 
Charlson Comorbidity Index 1.04 [1.03, 1.05] 
Female 1.00 [0.95, 1.06] 
Malignancies 1.61 [1.48, 1.76] 
Renal failure 1.50 [1.40, 1.60] 
Diabetes mellitus 1.03 [0.96, 1.11] 







































Figure 4.1. Percent exposed to infected prior bed occupants and roommates in controls versus cases of healthcare-associated infection 
with Staphylococcus aureus, Acinetobacter baumannii, Streptococcus pneumoniae, Pseudomonas aeruginosa, Klebsiella pneumoniae, 










































































 The aim of this dissertation was to describe the extent to which healthcare-associated 
infections (HAIs) continue to plague acute care hospitals and to evaluate the role of prior bed 
occupants and concurrent hospital roommates in infection transmission.  In pursuit of this aim, 
three related studies were conducted.  The first was a seven-year retrospective cohort study 
examining changes in the incidence and antimicrobial susceptibility of HAIs in four New York 
City acute care hospitals.  The second was a systematic review of the literature on organism 
transmission from hospital roommates and prior room occupants.  The third was a case-control 
study in the same four hospitals examining the association between exposure to roommates or 
prior bed occupants with positive bacterial cultures and subsequent infection with the same 
organism. 
The descriptive analysis in Chapter Two revealed several important trends.  First, levels 
of antimicrobial resistance remained consistent throughout the study period for all organisms 
with the exception of P. aeruginosa, for which resistance increased, and K. pneumoniae, for 
which resistance decreased.  The relatively steady rates of resistance occurred in the setting of 
local and national efforts aimed at halting or reducing the proliferation of resistance genes in 
common healthcare-associated pathogens.  The fact that resistance rates were largely unchanged 
suggests that such efforts may have had some impact on slowing their growth.   
Another significant finding from this analysis is that patients admitted from other 
healthcare facilities and those who had been previously admitted to one of the study hospitals 
were more likely to have antibiotic resistant versus sensitive infections.  This result is not 
surprising due to the fact that such patients have greater exposure to drug-resistant organisms and 
to antibiotics. Nevertheless, it is troubling because the proportion of patients with previous 




observed nationally.  This result highlights the importance of reducing environmental 
contamination through enhanced cleaning methods, since an increasing number of patients may 
harbor drug-resistant organisms as a result of repeated hospitalizations and stays in long-term or 
sub-acute care facilities.   
Chapter Two also revealed that the overall incidence of HAIs dropped significantly from 
2006 to 2012.  Since patient comorbidities and host factors have remained stable over time, this 
suggests that some infection prevention strategies have been effective.  Like many organizations 
across the United States, the Department of Infection Prevention and Control at the study 
hospitals instituted a number of new initiatives aimed at curbing infection rates, including central 
line care bundles, policies for the expedient removal of urinary catheters, hand hygiene 
monitoring, universal contact precautions, universal and targeted screening for multidrug-
resistant organisms, revised cleaning procedures and products, and countless other efforts.  The 
number of concurrent changes, the unit-specific implementation of some programs, and the 
brevity of some policies makes it impossible to retrospectively attribute HAI reductions to any 
one specific initiative.  Given the heterogeneous etiology of HAIs and the multitude of points 
along the transmission pathway at which the chain can be broken, it is likely that each of these 
initiatives played some role in preventing a small portion of infections.  The unfortunate reality is 
that given the complexity of this issue, optimal infection prevention will undoubtedly involve a 
combination of many strategies, each targeting different points in the infection transmission 
pathway.  The fact that HAI incidence remained high at 19.3 per 1,000 admissions at the end of 
the study period, after reductions had already occurred, indicates a need for further advances in 




In this dissertation, the focus was on the patient room as a pathogen reservoir.  Chapter 
Three summarizes a review of the existing literature regarding the risk posed to patients by 
infected or colonized previous room occupants and roommates.  Although findings were mixed, 
the majority of previously published articles reported a statistically significant positive 
association while only one identified a statistically significant negative association.  Insufficient 
power was a common theme throughout the studies, which may explain why many failed to 
detect any association between exposure to prior occupants or roommates and organism 
acquisition. 
 Chapter Four describes the largest and most comprehensive study to date of the 
association between exposures to infected or colonized previous room occupants or roommates 
and subsequent infection with the same organism.  In addition to overcoming the insufficient 
power faced by previous studies and including a wider range of bacterial species, this study also 
focused specifically on the outcome of infection, as opposed to organism acquisition, which 
includes both colonization and infection.  This allowed for a more precise estimation of the real 
impact that exposure to infected or colonized roommates and previous bed occupants can have 
on patients and hospitals in terms of actual HAIs.  In this seven-year case-control study of 
761,426 admissions across four acute care hospitals, exposure to an infected or colonized prior 
bed occupant conferred a nearly six-fold increase in the odds of infection and exposure to an 
infected or colonized roommate conferred a nearly five-fold increase.      
Overall, the proportion of cases exposed to infected or colonized prior bed occupants and 
roommates were relatively low at about two percent and four percent, respectively.  Still, it is 
important to keep in mind that the prior room occupant exposure defined in this study likely 




long periods of time, sources of exposure could include patients who were discharged from a 
room days, weeks, or months earlier.  Similarly, incubation periods vary, meaning that 
roommates from one or two weeks prior to infection could be sources of exposure.   
Taken together, these findings lend support to the hypothesis that the environment plays a 
significant role in the transmission of HAIs within the hospital setting.  The data suggest that 
patient-to-patient transmission does occur indirectly with the hospital room serving as a mediator 
and reservoir for pathogens.  The results of this dissertation have important practical implications 
for infection prevention and control.  For one, the “foam in, foam out” hand hygiene paradigm 
whereby healthcare workers are encouraged to perform hand hygiene upon entry and exit to each 
room may need to be revisited, since contamination inside patient rooms likely includes a host of 
potential pathogens left behind by previous room occupants or spread around by current 
roommates, which can be picked up by healthcare workers’ hands or gloves and brought directly 
to the patient.  For another, a review of current policies and procedures for routine cleaning in 
shared hospital rooms and terminal cleaning at discharge is warranted.  The evidence from this 
study suggests that although costly, effective interventions for room disinfection like ultraviolet 
light may be lifesaving.  Hospitals needing to make a business case to justify the investment in 
enhanced room cleaning should carefully weigh the expense of these measures against the costs 
of treating preventable HAIs. 
Public health relevance 
 In addition to the high fatality rates attributable to infections with multidrug-resistant 
bacteria, patients with difficult-to-treat infections can suffer serious morbidity, including 
amputations and multi-organ failure.10 However, the risks associated with pathogenic bacteria in 




of HAIs has important public health implications both within and beyond the hospital setting.  
Advances in patient care along with cost containment pressures have led to shorter hospital stays 
and more outpatient treatment, accelerating the opportunity for organisms that were once 
confined to hospitals to proliferate in the community.130,131  Higher rates of HAI transmission 
result in an increased need for antimicrobial prescriptions, which can negatively affect selection 
pressures inside healthcare facilities and in the environment more generally, potentially leading 
to further antimicrobial resistance.132  Furthermore, the connection between bacterial 
contamination in hospitals and the community is not limited to patients.  Public water supplies, 
for example, may be at risk of contamination with antibiotic-resistant pathogens from hospital 
waste water.133  The many points of interface between hospital and community underscore the 
public health importance of minimizing microbial contamination in healthcare settings through 
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